BIOMAT Database Logo BIOMAT Database Logo

High-dose metoclopramide: control of dacarbazine-induced emesis in a preliminary trial. 1982

L B Tyson, and R A Clark, and R J Gralla

UI MeSH Term Description Entries
D008787 Metoclopramide A dopamine D2 antagonist that is used as an antiemetic. 4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide,Cerucal,Maxolon,Metaclopramide,Metoclopramide Dihydrochloride,Metoclopramide Hydrochloride,Metoclopramide Monohydrochloride,Metoclopramide Monohydrochloride, Monohydrate,Primperan,Reglan,Rimetin,Dihydrochloride, Metoclopramide,Hydrochloride, Metoclopramide,Monohydrochloride, Metoclopramide
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003606 Dacarbazine An antineoplastic agent. It has significant activity against melanomas. (from Martindale, The Extra Pharmacopoeia, 31st ed, p564) DTIC,5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide,Biocarbazine,DIC,DTIC-Dome,Decarbazine,Deticene,Dimethyl Imidazole Carboxamide,Dimethyl Triazeno Imidazole Carboxamide,ICDT,NSC-45388,Carboxamide, Dimethyl Imidazole,DTIC Dome,DTICDome,Imidazole Carboxamide, Dimethyl,NSC 45388,NSC45388
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014839 Vomiting The forcible expulsion of the contents of the STOMACH through the MOUTH. Emesis

Related Publications

L B Tyson, and R A Clark, and R J Gralla
A randomized trial of high dose bolus metoclopramide versus low-dose continuous infusion metoclopramide in the prevention of cisplatin-induced emesis.
June 1987, American journal of clinical oncology,
L B Tyson, and R A Clark, and R J Gralla
[Improved control of cisplatin-induced emesis with high-dose metoclopramide, dexamethasone and lorazepam].
February 1991, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed,
L B Tyson, and R A Clark, and R J Gralla
[Effectiveness of high-dose metoclopramide in the control of acute emesis induced by chemotherapy].
March 1987, Medicina clinica,
L B Tyson, and R A Clark, and R J Gralla
[Randomized control study of high-dose metoclopramide in the prevention of CDDP-induced emesis].
April 1985, Gan to kagaku ryoho. Cancer & chemotherapy,
L B Tyson, and R A Clark, and R J Gralla
High-dose metoclopramide in the treatment of cis-platinum induced emesis. A dose-finding study.
January 1985, Neoplasma,
L B Tyson, and R A Clark, and R J Gralla
A prospective, randomized double-blind trial comparing metoclopramide alone with metoclopramide plus dexamethasone in preventing emesis induced by high-dose cisplatin.
November 1988, Cancer,
L B Tyson, and R A Clark, and R J Gralla
Ondansetron for the control of dacarbazine-induced emesis.
September 1995, European journal of cancer (Oxford, England : 1990),
L B Tyson, and R A Clark, and R J Gralla
High-dose metoclopramide and chlorpromazine in the treatment of cisplatin-induced emesis.
May 1987, Pharmacology & toxicology,
L B Tyson, and R A Clark, and R J Gralla
Optimizing metoclopramide control of cisplatin-induced emesis.
March 1984, Annals of internal medicine,
L B Tyson, and R A Clark, and R J Gralla
Amelioration of cytotoxic-induced emesis with high-dose metoclopramide, dexamethasone and lorazepam.
January 1987, Cancer chemotherapy and pharmacology,
Copied contents to your clipboard!